Jobs / United States / Glaxosmithkline LLC
Medical Science Liaison - Hepatology
Glaxosmithkline LLC · 🇺🇸 Field Worker - MEX
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles8 certified filings for “Principal Scientist” (Medical Scientists, Except Epidemiologists) in PA: $98k–$110k, median $98k. Most were filed at wage level I (63%) — 1 lottery entry, ≈15% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Position Summary You will be a field-based scientific partner working with healthcare professionals and internal teams to support clinical development and medical strategy in Mexico. You will build trusted scientific relationships, share up-to-date evidence, and bring practical insights back to Medical Affairs and clinical teams. We value clear communicators who work collaboratively, act with integrity, and want to make a meaningful difference for patients. This role offers growth, learning, and the chance to contribute to GSK’s mission of uniting science, technology and talent to get ahead of disease together. This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: • Develop and maintain peer-to-peer scientific collaborations and compliant relationships with key external medical experts in relevant therapeutic areas (e.g. respiratory, immunology), engaging them in robust scientific dialogue that generates insights and advances scientific and medical understanding. • Serve as a scientific, clinical and medical content expert, delivering factual, non-promotional scientific exchange to support clinical trials, research, and education. • Identify, consolidate and communicate key external insights, and contribute to translating these into executable and innovative Medical Affairs strategies that inform GSK’s scientific, clinical and access plans. • Support investigator engagement for study feasibility, site start-up, and trial conduct activities. • Collaborate within matrix and cross-functional teams (e.g. Medical Directors, Medical Communications, Medical Information, Publications, Advocacy). • Perform all responsibilities in strict compliance with applicable regulations, standard operating procedures, industry practices, and all GSK policies and safety guidelines relevant to the MSL and Medical Affairs organization. Why You? We are seeking candidates who are motivated to engage with experts, support clinical research, and help shape medical strategy in Mexico. The role is field-based with hybrid working arrangements and requires regular travel within your assigned territory. You will join a supportive team that values coaching, open communication, and professional development. Basic Qualification We are seeking professionals with the following required skills and qualifications to help us achieve our goals: • University degree in medicine, pharmacy, life sciences or equivalent clinical/scientific qualification. • Educational background in infectious diseases, gastroenterology, hepatology, or internal medicine. • Minimum 2 years of relevant experience in Medical Affairs, clinical research, clinical development, or a related role within the pharmaceutical or healthcare industry. • Strong verbal and written communication skills in English. • Availability to travel 50% of the time. • Understanding of clinical research principles, good clinical practice and the ability to follow regulatory and compliance requirements. Preferred Qualification If you have the following characteristics, it would be a plus: • Previous experience as a Medical Science Liaison, Medical Advisor or similar medical affairs roles Ready to apply? If this role excites you, please submit your CV. Skills Business Insights, Collaboration, Communication, Digital Fluency, External Stakeholder Management Why GSK? Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can th